Myrto Moutafi

Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma

S. Theocharis, H. Gakiopoulou, Myrto K Moutafi, 2022, International journal of molecular sciences.

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

R. Herbst, D. Rimm, S. Langermann, 2022, Laboratory Investigation.

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Yan Song, D. Rimm, K. Bloom, 2022, Laboratory Investigation.

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms

D. Rimm, K. Ikenberg, J. Wilmott, 2022, EBioMedicine.

Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists.

L. Pantanowitz, J. Taube, Dafydd G. Thomas, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

R. Herbst, D. Rimm, K. Schalper, 2022, Journal for ImmunoTherapy of Cancer.

Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case–control study

L. Pusztai, D. Rimm, K. Blenman, 2021, Breast Cancer Research.

Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

D. Rimm, A. Psyrri, E. Kyrodimos, 2023, Cancer research communications.

Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases

S. Signoretti, T. Choueiri, D. Djureinovic, 2023, Journal for ImmunoTherapy of Cancer.

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance

D. Rimm, M. Hurwitz, H. Kluger, 2022, Frontiers in Oncology.